BioCentury
ARTICLE | Clinical News

PXL-01: Phase II data

July 16, 2012 7:00 AM UTC

Top-line data from a double-blind, European Phase II trial in 138 patients aged 15-65 undergoing flexor tendon repair surgery showed that 0.5 mL topical PXL-01 missed the primary endpoint of improving...